-
1
-
-
0042140649
-
Peptidomics-based discovery of novel neuropeptides
-
Svensson M, Skold K, Svenningsson P, Andren PE, (2003) Peptidomics-based discovery of novel neuropeptides. JProteomeRes 2: 213-219.
-
(2003)
JProteomeRes
, vol.2
, pp. 213-219
-
-
Svensson, M.1
Skold, K.2
Svenningsson, P.3
Andren, P.E.4
-
2
-
-
0037174927
-
Peptidomics of the larval Drosophila melanogaster central nervous system
-
Baggerman G, Cerstiaens A, DeLoof A, Schoofs L, (2002) Peptidomics of the larval Drosophila melanogaster central nervous system. JBiolChem 277: 40368-40374.
-
(2002)
JBiolChem
, vol.277
, pp. 40368-40374
-
-
Baggerman, G.1
Cerstiaens, A.2
DeLoof, A.3
Schoofs, L.4
-
3
-
-
0035047188
-
Peptidomics: the comprehensive analysis of peptides in complex biological mixtures
-
Schulz-Knappe P, Zucht HD, Heine G, Jurgens M, Hess R, et al. (2001) Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. CombChemHigh ThroughputScreen 4: 207-217.
-
(2001)
CombChemHigh ThroughputScreen
, vol.4
, pp. 207-217
-
-
Schulz-Knappe, P.1
Zucht, H.D.2
Heine, G.3
Jurgens, M.4
Hess, R.5
-
4
-
-
33750205820
-
Profiling signaling peptides in single mammalian cells using mass spectrometry
-
Rubakhin SS, Churchill JD, Greenough WT, Sweedler JV, (2006) Profiling signaling peptides in single mammalian cells using mass spectrometry. AnalChem 78: 7267-7272.
-
(2006)
AnalChem
, vol.78
, pp. 7267-7272
-
-
Rubakhin, S.S.1
Churchill, J.D.2
Greenough, W.T.3
Sweedler, J.V.4
-
5
-
-
33644879722
-
Peptidomics: Identification and quantification of endogenous peptides in neuroendocrine tissues
-
Fricker LD, Lim J, Pan H, Che FY, (2006) Peptidomics: Identification and quantification of endogenous peptides in neuroendocrine tissues. Mass SpectromRev 25: 327-344.
-
(2006)
Mass SpectromRev
, vol.25
, pp. 327-344
-
-
Fricker, L.D.1
Lim, J.2
Pan, H.3
Che, F.Y.4
-
6
-
-
77954573017
-
Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins
-
Fricker LD, (2010) Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. MolBiosyst 6: 1355-1365.
-
(2010)
MolBiosyst
, vol.6
, pp. 1355-1365
-
-
Fricker, L.D.1
-
7
-
-
67349275522
-
Peptidic modulators of protein-protein interactions: progress and challenges in computational design
-
Rubinstein M, Niv MY, (2009) Peptidic modulators of protein-protein interactions: progress and challenges in computational design. Biopolymers 91: 505-513.
-
(2009)
Biopolymers
, vol.91
, pp. 505-513
-
-
Rubinstein, M.1
Niv, M.Y.2
-
8
-
-
67649841614
-
The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions
-
Arkin MR, Whitty A, (2009) The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. CurrOpinChemBiol 13: 284-290.
-
(2009)
CurrOpinChemBiol
, vol.13
, pp. 284-290
-
-
Arkin, M.R.1
Whitty, A.2
-
9
-
-
54049117647
-
Intracellular peptides as natural regulators of cell signaling
-
Cunha FM, Berti DA, Ferreira ZS, Klitzke CF, Markus RP, et al. (2008) Intracellular peptides as natural regulators of cell signaling. JBiolChem 283: 24448-24459.
-
(2008)
JBiolChem
, vol.283
, pp. 24448-24459
-
-
Cunha, F.M.1
Berti, D.A.2
Ferreira, Z.S.3
Klitzke, C.F.4
Markus, R.P.5
-
10
-
-
84865563285
-
Identification of intracellular peptides in rat adipose tissue: insights into insulin resistance
-
Berti DA, Russo LC, Castro LM, Cruz L, Gozzo FC, et al. (2012) Identification of intracellular peptides in rat adipose tissue: insights into insulin resistance. Proteomics 12: 2668-2681.
-
(2012)
Proteomics
, vol.12
, pp. 2668-2681
-
-
Berti, D.A.1
Russo, L.C.2
Castro, L.M.3
Cruz, L.4
Gozzo, F.C.5
-
11
-
-
76849100919
-
The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans
-
Haynes CM, Yang Y, Blais SP, Neubert TA, Ron D, (2010) The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. MolCell 37: 529-540.
-
(2010)
MolCell
, vol.37
, pp. 529-540
-
-
Haynes, C.M.1
Yang, Y.2
Blais, S.P.3
Neubert, T.A.4
Ron, D.5
-
12
-
-
77954786287
-
Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis
-
Kondo T, Plaza S, Zanet J, Benrabah E, Valenti P, et al. (2010) Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis. Science 329: 336-339.
-
(2010)
Science
, vol.329
, pp. 336-339
-
-
Kondo, T.1
Plaza, S.2
Zanet, J.3
Benrabah, E.4
Valenti, P.5
-
13
-
-
8644245895
-
Intracellullar peptides as putative natural regulators of protein interactions
-
Ferro ES, Hyslop S, Camargo AC, (2004) Intracellullar peptides as putative natural regulators of protein interactions. JNeurochem 91: 769-777.
-
(2004)
JNeurochem
, vol.91
, pp. 769-777
-
-
Ferro, E.S.1
Hyslop, S.2
Camargo, A.C.3
-
14
-
-
0346727127
-
Protein degradation and protection against misfolded or damaged proteins
-
Goldberg AL, (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
-
(2003)
Nature
, vol.426
, pp. 895-899
-
-
Goldberg, A.L.1
-
15
-
-
53749096967
-
Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration
-
Vosler PS, Brennan CS, Chen J, (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. MolNeurobiol 38: 78-100.
-
(2008)
MolNeurobiol
, vol.38
, pp. 78-100
-
-
Vosler, P.S.1
Brennan, C.S.2
Chen, J.3
-
17
-
-
0035801514
-
Lysosomal cysteine proteases: facts and opportunities
-
Turk V, Turk B, Turk D, (2001) Lysosomal cysteine proteases: facts and opportunities. EMBO J 20: 4629-4633.
-
(2001)
EMBO J
, vol.20
, pp. 4629-4633
-
-
Turk, V.1
Turk, B.2
Turk, D.3
-
19
-
-
0024406166
-
Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides
-
Orlowski M, Reznik S, Ayala J, Pierotti AR, (1989) Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides. BiochemJ 261: 951-958.
-
(1989)
BiochemJ
, vol.261
, pp. 951-958
-
-
Orlowski, M.1
Reznik, S.2
Ayala, J.3
Pierotti, A.R.4
-
20
-
-
0032497243
-
Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15
-
Rioli V, Kato A, Portaro FC, Cury GK, te KK, et al. (1998) Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. BiochemBiophysResCommun 250: 5-11.
-
(1998)
BiochemBiophysResCommun
, vol.250
, pp. 5-11
-
-
Rioli, V.1
Kato, A.2
Portaro, F.C.3
Cury, G.K.4
te, K.K.5
-
21
-
-
0029007055
-
Thimet oligopeptidase and oligopeptidase M or neurolysin
-
Barrett AJ, Brown MA, Dando PM, Knight CG, McKie N, et al. (1995) Thimet oligopeptidase and oligopeptidase M or neurolysin. Methods Enzymol 248: 529-556.
-
(1995)
Methods Enzymol
, vol.248
, pp. 529-556
-
-
Barrett, A.J.1
Brown, M.A.2
Dando, P.M.3
Knight, C.G.4
McKie, N.5
-
22
-
-
8744237281
-
Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases
-
Saric T, Graef CI, Goldberg AL, (2004) Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases. JBiolChem 279: 46723-46732.
-
(2004)
JBiolChem
, vol.279
, pp. 46723-46732
-
-
Saric, T.1
Graef, C.I.2
Goldberg, A.L.3
-
23
-
-
33846955435
-
Prolyl endopeptidases
-
Gass J, Khosla C, (2007) Prolyl endopeptidases. Cell MolLife Sci 64: 345-355.
-
(2007)
Cell MolLife Sci
, vol.64
, pp. 345-355
-
-
Gass, J.1
Khosla, C.2
-
24
-
-
66249126847
-
The proteolytic activity of insulin-degrading enzyme: A mass spectrometry study
-
Grasso G, Rizzarelli E, Spoto G (2009) The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study. JMass Spectrom.
-
(2009)
JMass Spectrom.
-
-
Grasso, G.1
Rizzarelli, E.2
Spoto, G.3
-
25
-
-
78650310807
-
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes
-
Kessler JH, Khan S, Seifert U, Le Gall S, Chow KM, et al. (2011) Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol 12: 45-53.
-
(2011)
Nat Immunol
, vol.12
, pp. 45-53
-
-
Kessler, J.H.1
Khan, S.2
Seifert, U.3
Le Gall, S.4
Chow, K.M.5
-
26
-
-
67649804558
-
Analysis of intracellular substrates and products of thimet oligopeptidase (EC 3.4.24.15) in human embryonic kidney 293 cells
-
Berti DA, Morano C, Russo LC, Castro LM, Cunha FM, et al. (2009) Analysis of intracellular substrates and products of thimet oligopeptidase (EC 3.4.24.15) in human embryonic kidney 293 cells. JBiolChem 284: 14105-14116.
-
(2009)
JBiolChem
, vol.284
, pp. 14105-14116
-
-
Berti, D.A.1
Morano, C.2
Russo, L.C.3
Castro, L.M.4
Cunha, F.M.5
-
27
-
-
33751550951
-
Leucine aminopeptidases: diversity in structure and function
-
Matsui M, Fowler JH, Walling LL, (2006) Leucine aminopeptidases: diversity in structure and function. BiolChem 387: 1535-1544.
-
(2006)
BiolChem
, vol.387
, pp. 1535-1544
-
-
Matsui, M.1
Fowler, J.H.2
Walling, L.L.3
-
28
-
-
1842785206
-
A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation
-
Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, et al. (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20: 495-506.
-
(2004)
Immunity
, vol.20
, pp. 495-506
-
-
Reits, E.1
Neijssen, J.2
Herberts, C.3
Benckhuijsen, W.4
Janssen, L.5
-
29
-
-
84857822899
-
Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides
-
Fricker LD, Gelman JS, Castro LM, Gozzo FC, Ferro ES, (2012) Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides. J Proteome Res 11: 1981-1990.
-
(2012)
J Proteome Res
, vol.11
, pp. 1981-1990
-
-
Fricker, L.D.1
Gelman, J.S.2
Castro, L.M.3
Gozzo, F.C.4
Ferro, E.S.5
-
30
-
-
79953686243
-
Peptidomic analysis of human cell lines
-
Gelman JS, Sironi J, Castro LM, Ferro ES, Fricker LD, (2011) Peptidomic analysis of human cell lines. JProteomeRes 10: 1583-1592.
-
(2011)
JProteomeRes
, vol.10
, pp. 1583-1592
-
-
Gelman, J.S.1
Sironi, J.2
Castro, L.M.3
Ferro, E.S.4
Fricker, L.D.5
-
31
-
-
0343262654
-
Crystal structure of epoxomicin: 20S proteasome reveals a molecular basis for selectivity of alpha ',beta '-epoxyketone proteasome inhibitors
-
Groll M, Kim KB, Kairies N, Huber R, Crews CM, (2000) Crystal structure of epoxomicin: 20S proteasome reveals a molecular basis for selectivity of alpha ',beta '-epoxyketone proteasome inhibitors. Journal of the American Chemical Society 122: 1237-1238.
-
(2000)
Journal of the American Chemical Society
, vol.122
, pp. 1237-1238
-
-
Groll, M.1
Kim, K.B.2
Kairies, N.3
Huber, R.4
Crews, C.M.5
-
32
-
-
33745728140
-
Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132
-
Crawford LJ, Walker B, Ovaa H, Chauhan D, Anderson KC, et al. (2006) Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132. Cancer Res 66: 6379-6386.
-
(2006)
Cancer Res
, vol.66
, pp. 6379-6386
-
-
Crawford, L.J.1
Walker, B.2
Ovaa, H.3
Chauhan, D.4
Anderson, K.C.5
-
33
-
-
18244406798
-
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib
-
Berkers CR, Verdoes M, Lichtman E, Fiebiger E, Kessler BM, et al. (2005) Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib. NatMethods 2: 357-362.
-
(2005)
NatMethods
, vol.2
, pp. 357-362
-
-
Berkers, C.R.1
Verdoes, M.2
Lichtman, E.3
Fiebiger, E.4
Kessler, B.M.5
-
34
-
-
61849149936
-
Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format
-
Moravec RA, O'Brien MA, Daily WJ, Scurria MA, Bernad L, et al. (2009) Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format. AnalBiochem 387: 294-302.
-
(2009)
AnalBiochem
, vol.387
, pp. 294-302
-
-
Moravec, R.A.1
O'Brien, M.A.2
Daily, W.J.3
Scurria, M.A.4
Bernad, L.5
-
35
-
-
54049085820
-
Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway
-
Lioni M, Noma K, Snyder A, Klein-Szanto A, Diehl JA, et al. (2008) Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. MolCancer Ther 7: 2866-2875.
-
(2008)
MolCancer Ther
, vol.7
, pp. 2866-2875
-
-
Lioni, M.1
Noma, K.2
Snyder, A.3
Klein-Szanto, A.4
Diehl, J.A.5
-
37
-
-
46049100809
-
Bortezomib: a novel chemotherapeutic agent for hematologic malignancies
-
Utecht KN, Kolesar J, (2008) Bortezomib: a novel chemotherapeutic agent for hematologic malignancies. AmJHealth SystPharm 65: 1221-1231.
-
(2008)
AmJHealth SystPharm
, vol.65
, pp. 1221-1231
-
-
Utecht, K.N.1
Kolesar, J.2
-
38
-
-
14744270672
-
Quantitative peptidomics of mouse pituitary: Comparison of different stable isotopic tags
-
Che FY, Fricker LD, (2005) Quantitative peptidomics of mouse pituitary: Comparison of different stable isotopic tags. JMass Spectrom 40: 238-249.
-
(2005)
JMass Spectrom
, vol.40
, pp. 238-249
-
-
Che, F.Y.1
Fricker, L.D.2
-
39
-
-
57449116568
-
Multiple Isotopic Labels for Quantitative Mass Spectrometry
-
Morano C, Zhang X, Fricker LD, (2008) Multiple Isotopic Labels for Quantitative Mass Spectrometry. AnalChem 80: 9298-9309.
-
(2008)
AnalChem
, vol.80
, pp. 9298-9309
-
-
Morano, C.1
Zhang, X.2
Fricker, L.D.3
-
40
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
-
Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. JImmunolMethods 65: 55-63.
-
(1983)
JImmunolMethods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
41
-
-
38049037238
-
Optimization of neuropeptide extraction from the mouse hypothalamus
-
Che FY, Zhang X, Berezniuk I, Callaway M, Lim J, et al. (2007) Optimization of neuropeptide extraction from the mouse hypothalamus. JProteomeRes 6: 4667-4676.
-
(2007)
JProteomeRes
, vol.6
, pp. 4667-4676
-
-
Che, F.Y.1
Zhang, X.2
Berezniuk, I.3
Callaway, M.4
Lim, J.5
-
42
-
-
56749132145
-
Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing
-
Zhang X, Che FY, Berezniuk I, Sonmez K, Toll L, et al. (2008) Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing. JNeurochem 107: 1596-1613.
-
(2008)
JNeurochem
, vol.107
, pp. 1596-1613
-
-
Zhang, X.1
Che, F.Y.2
Berezniuk, I.3
Sonmez, K.4
Toll, L.5
-
43
-
-
77449152998
-
Understanding and exploiting Peptide fragment ion intensities using experimental and informatic approaches
-
Gucinski AC, Dodds ED, Li W, Wysocki VH, (2010) Understanding and exploiting Peptide fragment ion intensities using experimental and informatic approaches. Methods Mol Biol 604: 73-94.
-
(2010)
Methods Mol Biol
, vol.604
, pp. 73-94
-
-
Gucinski, A.C.1
Dodds, E.D.2
Li, W.3
Wysocki, V.H.4
-
44
-
-
2642551603
-
Development of the proteasome inhibitor Velcade (Bortezomib)
-
Adams J, Kauffman M, (2004) Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest 22: 304-311.
-
(2004)
Cancer Invest
, vol.22
, pp. 304-311
-
-
Adams, J.1
Kauffman, M.2
-
45
-
-
33646841837
-
Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate
-
Kisselev AF, Callard A, Goldberg AL, (2006) Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. JBiolChem 281: 8582-8590.
-
(2006)
JBiolChem
, vol.281
, pp. 8582-8590
-
-
Kisselev, A.F.1
Callard, A.2
Goldberg, A.L.3
-
46
-
-
66349117098
-
The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB
-
Fontanini A, Foti C, Potu H, Crivellato E, Maestro R, et al. (2009) The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB. JBiolChem 284: 8369-8381.
-
(2009)
JBiolChem
, vol.284
, pp. 8369-8381
-
-
Fontanini, A.1
Foti, C.2
Potu, H.3
Crivellato, E.4
Maestro, R.5
-
47
-
-
66249085237
-
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib
-
Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, et al. (2009) The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 69: 4415-4423.
-
(2009)
Cancer Res
, vol.69
, pp. 4415-4423
-
-
Milani, M.1
Rzymski, T.2
Mellor, H.R.3
Pike, L.4
Bottini, A.5
-
48
-
-
46249115957
-
Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation
-
Harada M, Hanada S, Toivola DM, Ghori N, Omary MB, (2008) Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. Hepatology 47: 2026-2035.
-
(2008)
Hepatology
, vol.47
, pp. 2026-2035
-
-
Harada, M.1
Hanada, S.2
Toivola, D.M.3
Ghori, N.4
Omary, M.B.5
-
49
-
-
66449121341
-
Aminopeptidase inhibition as a targeted treatment strategy in myeloma
-
Moore HE, Davenport EL, Smith EM, Muralikrishnan S, Dunlop AS, et al. (2009) Aminopeptidase inhibition as a targeted treatment strategy in myeloma. MolCancer Ther 8: 762-770.
-
(2009)
MolCancer Ther
, vol.8
, pp. 762-770
-
-
Moore, H.E.1
Davenport, E.L.2
Smith, E.M.3
Muralikrishnan, S.4
Dunlop, A.S.5
-
50
-
-
0034037622
-
Proteasome inhibition measurements: clinical application
-
Lightcap ES, McCormack TA, Pien CS, Chau V, Adams J, et al. (2000) Proteasome inhibition measurements: clinical application. ClinChem 46: 673-683.
-
(2000)
ClinChem
, vol.46
, pp. 673-683
-
-
Lightcap, E.S.1
McCormack, T.A.2
Pien, C.S.3
Chau, V.4
Adams, J.5
-
51
-
-
27644562277
-
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
-
Chauhan D, Catley L, Li G, Podar K, Hideshima T, et al. (2005) A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. Cancer Cell 8: 407-419.
-
(2005)
Cancer Cell
, vol.8
, pp. 407-419
-
-
Chauhan, D.1
Catley, L.2
Li, G.3
Podar, K.4
Hideshima, T.5
-
52
-
-
77952340703
-
Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation
-
Li C, Chen S, Yue P, Deng X, Lonial S, et al. (2010) Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation. J Biol Chem 285: 16096-16104.
-
(2010)
J Biol Chem
, vol.285
, pp. 16096-16104
-
-
Li, C.1
Chen, S.2
Yue, P.3
Deng, X.4
Lonial, S.5
-
53
-
-
45849099115
-
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition
-
Nickeleit I, Zender S, Sasse F, Geffers R, Brandes G, et al. (2008) Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition. Cancer Cell 14: 23-35.
-
(2008)
Cancer Cell
, vol.14
, pp. 23-35
-
-
Nickeleit, I.1
Zender, S.2
Sasse, F.3
Geffers, R.4
Brandes, G.5
-
54
-
-
79955498420
-
Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events
-
Arastu-Kapur S, Anderl JL, Kraus M, Parlati F, Shenk KD, et al. (2011) Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events. Clin Cancer Res 17: 2734-2743.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2734-2743
-
-
Arastu-Kapur, S.1
Anderl, J.L.2
Kraus, M.3
Parlati, F.4
Shenk, K.D.5
-
55
-
-
0036680037
-
Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer
-
Adams J, (2002) Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer. CurrOpinChemBiol 6: 493-500.
-
(2002)
CurrOpinChemBiol
, vol.6
, pp. 493-500
-
-
Adams, J.1
-
56
-
-
0033152760
-
Proteasome inhibitors: a novel class of potent and effective antitumor agents
-
Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, et al. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59: 2615-2622.
-
(1999)
Cancer Res
, vol.59
, pp. 2615-2622
-
-
Adams, J.1
Palombella, V.J.2
Sausville, E.A.3
Johnson, J.4
Destree, A.5
-
57
-
-
60849126138
-
Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor
-
Kravtsova-Ivantsiv Y, Cohen S, Ciechanover A, (2009) Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor. MolCell 33: 496-504.
-
(2009)
MolCell
, vol.33
, pp. 496-504
-
-
Kravtsova-Ivantsiv, Y.1
Cohen, S.2
Ciechanover, A.3
-
58
-
-
84865563623
-
Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3 epsilon and calmodulin
-
Russo LC, Asega AF, Castro LM, Negraes PD, Cruz L, et al. (2012) Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3 epsilon and calmodulin. Proteomics 12: 2641-2655.
-
(2012)
Proteomics
, vol.12
, pp. 2641-2655
-
-
Russo, L.C.1
Asega, A.F.2
Castro, L.M.3
Negraes, P.D.4
Cruz, L.5
|